Kimberly M. Murphy serves as Executive at Clarus Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Kimberly M. Murphy has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 8, 2023 involved receiving (via award) 25,000 shares valued at $0.
Kimberly M. Murphy currently holds 25,000 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kimberly M. Murphy has been a net neutral trader of CRXT stock. They have purchased $0 and sold $0 worth of shares.
Kimberly M. Murphy's most recent insider trade was on Aug 8, 2023, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 12, 2021 | CRXT | $0 | Award | 3,844 | $N/A | Discretionary |